Study of unexplained high liver enzymes
Part of Cancer, Digestive system clinical trials.
This study is looking at people with unexplained high liver enzymes (ALT or AST) that have persisted for at least 6 months. Researchers want to understand what might be causing these elevations and are comparing them to people with normal liver tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your liver enzymes (ALT or AST) have been higher than normal for at least 6 months, and doctors haven't found a cause yet.
- You have not been diagnosed with fatty liver disease (MASLD), alcohol-related liver disease, viral hepatitis, or other known genetic liver conditions.
- You do not have celiac disease, thyroid problems, muscle disease, active infection, or cancer.
- You haven't taken antibiotics or probiotics in the last 3 months, and you're not on immune-suppressing drugs.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to understand the genetic factors behind metabolic fatty liver disease (MASLD) by comparing patients with advanced liver scarring or liver cancer to healthy blood donors. It may help doctors better predict and treat the disease in the future.
This study collects information about metabolic and unexplained (cryptogenic) liver disease and looks at “omics” tests, which are lab tests that measure patterns in blood or tissue to learn what drives the disease. It may help researchers better understand fatty liver and related serious complications, like liver scarring and liver cancer.
This study looks at factors that predict liver cancer and the need for a liver transplant in people with a liver condition called MASLD (metabolic dysfunction-associated steatotic liver disease). The goal is to better understand the disease and improve care.
This study tests a more detailed way to examine the liver in people with fatty liver disease who also have other health risks. The doctors want to see if this extra testing helps decide whether you need treatment.
This study looks for better ways to find and diagnose hepatitis when the cause is not clear. If you join, doctors will monitor your condition and test samples to try to identify what's causing your liver inflammation.
This study is testing whether advanced imaging and other non-invasive methods can properly identify people with significant liver scarring due to metabolic liver disease or alcohol-related liver disease. It may help find better ways to track liver health without repeated needle biopsies.
Hear when a new Cryptogenic Hypertransaminasemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.